Histologic and histomorphometric evaluation of an allograft stem cell-based matrix sinus augmentation procedure

International Journal of Oral and Maxillofacial Implants

Volumn 26, Issue 1, 2011, Pages 123-131

  Gonshor, Aron ^a   McAllister, Bradley S ^b,c   Wallace, Stephen S ^d   Prasad, Hari ^e  

^a MCGILL UNIVERSITY   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c New York University College of Dentistry ^*  (United States)

^d NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bone regeneration; Osteoblasts; Ridge augmentation; Stem cells; Tissue engineering

Indexed keywords

ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; BIOPSY; BONE DEVELOPMENT; BONE MATRIX; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMAGE PROCESSING; JAW; MALE; MAXILLA; MAXILLARY SINUS; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; ORAL SURGERY; PATHOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TISSUE PRESERVATION; TRANSPLANTATION; WOUND HEALING;

ADULT; AGED; ALVEOLAR PROCESS; ALVEOLAR RIDGE AUGMENTATION; BIOPSY; BONE MATRIX; CRYOPRESERVATION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MAXILLA; MAXILLARY SINUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; OSTEOGENESIS; TISSUE PRESERVATION; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING;

EID: 79955022165     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Beaumont C, Schmidt RJ, Tatakis DN, Zafiroponlos GG. Use of engineered bone for sinus augmentation. J Periodontol 2008; 79:541-548.
2. Becker W, Becker B, Caffesse R. A comparison of demineralized freeze-dried bone and autologous bone to induce bone formation in human extraction sockets. J Periodontol 1994; 65:1128-1133.
3. Berglundh T, Lindhe J. Healing around implants placed in bone defects treated with Bio-Oss. An experimental study in the dog. Clin Oral Implants Res 1997; 8:117-124.
4. Schmelzeisen R, Schimming R, Sittinger M. Making bone:Implant insertion into tissue-engineered bone for maxillary sinus floor augmentation-A preliminary report. J Craniomaxillofac Surg 2003; 31:34-39.
5. Turhani D, Watzinger E, Weissenbock M. Three-dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation:An in vitro study. Clin Oral Implants Res 2005; 16:417-424.
6. Zizelmann C, Schoen R, Metzger MC. Bone formation after sinus augmentation with engineered bone. Clin Oral Implants Res 2007; 18:69-73.
7. McAllister B, Haghighat K. Bone augmentation techniques. J Periodontol 2007; 78:377-396.
8. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg 2005; 87:1430-1437.
9. Younger E, Chapman M. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3:192-195.
10. Hollinger J, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop Relat Res 1996; 324:55-65.
11. Holmes R, Hagler H. Porous hydroxyapatite as a bone graft substitute in cranial reconstruction: A histometric study. Plast Reconstr Surg 1988; 81:662-671.
12. Einhorn T, Lane JM, Burstein AH, Kopman CR, Vigorita VJ. The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. J Bone Joint Surg Am 1984; 66:274-279.
13. Margolin M, Cogan AG, Taylor M, et al. Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. J Periodontol 1998; 69:911-919.
14. Wozney J, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998; 346:26-37.
15. Muschler G, Nakamoto C, Griffith L. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004; 86:1541-1558.
16. Pittenger M, Martin B. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95:9-20.
17. Yoo JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998; 80:1745-1757.
18. Bruder S, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998; 80:985-996.
19. McAllister B. Stem cell-containing allograft matrix enhances periodontal regeneration: Case presentations. Int J Periodontics Restorative Dent 2011;31(in press).
20. Bruder S, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997; 21:225-235.
21. Thomson J, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
22. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997; 6:125-134.
23. Malekzadeh R, Hollinger JO, Buck D, Adams DF, McAllister BS. Isolation of human osteoblast-like cells and in vitro amplification for tissue engineering. J Periodontol 1998; 69:1256-1262.
24. Arinzeh T, Peter SJ, Archambault MP, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003; 85:1927-1135.
25. Bruder S, Fink D, Caplan A. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994; 56:283-294.
26. Bruder S, Jaiswal N, Ricalton NS, et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998;355(suppl):S247-S256.
27. Bruder S, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, cultureexpanded human mesenchymal stem cells. J Orthop Res 1998; 16:155-162.
28. De Kok I, Peter SJ, Archambault M, et al. Investigation of allogeneic mesenchyrnal stem cell-based alveolar bone formation:Preliminary findings. Clin Oral Implants Res 2003; 14:481-489.
29. Noshi T, Yoshikawa T, Dohi Y, et al. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs 2001; 3:201-208.
30. Del Fabbro M, Testori T, Francetti L, Weinstein R. Systematic review of survival rates for implants placed in the grafted maxillary sinus. Int J Periodontics Restorative Dent 2004; 24:565-577.
31. Wallace S, Froum S. Effect of maxillary sinus augmentation on the survival of endosseous dental implants. A systematic review. Ann Periodontol 2003; 8:328-343.
32. McAllister BS, Margolin MD, Cogan AG, Taylor M, Wollins J. Residual lateral wall defects following sinus grafting with recombinant human osteogenic protein-1 or Bio-Oss in the chimpanzee. Int J Periodontics Restorative Dent 1998; 18:227-239.
33. Wheeler S, Holmes R, Calhoun C. Six-year clinical and histologic study of sinus-lift grafts. Int J Oral Maxillofac implants 1996; 11:26-34.
34. McAllister B, Haghighat K, Gonshor A. Histologic evaluation of a stem cell-based sinus-augmentation procedure. J Periodontol 2009; 80:679-686.
35. Pittenger M, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147.
36. Smiler D, Soltan M, Albitar M. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration. Implant Dent 2008; 17:236-247.
37. Strober W. Trypan blue exclusion test of cell viability. In:Coligan JE (ed). Current Protocols in Immunology. Hoboken, NJ: John Wiley and Sons, 2001.
38. Boyan B, Bonewald LF, Paschalis EP, et al. Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography. Calcif Tissue Int 2002; 71:519-529.
39. Ishaug-Riley S, Okun LE, Prado G, Applegate MA, Ratcliffe A. Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. Biomaterials 1999; 20:2245-2256.
40. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues: The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 1982; 11:318-326.
41. Rohrer M, Schubert C. The cutting-grinding technique for histologic preparation of undecalcified bone and boneanchored implants: Improvements in instrumentation and procedures. Oral Surg Oral Med Oral Pathol1992; 74:73-78.
42. Watzek G, Ulm C, Haas R. Anatomic and physiologic fundamentals of sinus floor augmentation. In: Jensen O (ed). The Sinus Bone Graft. Chicago: Quintessence, 1999:35-37.
43. McAllister BS, Haghighat K, Prasad HS, Rohrer MD. Histologic evaluation of recombinant human platelet-derived growth factor-BB after use in extraction socket defects: A case series. Int J Periodontics Restorative Dent 2010; 30:365-373.
44. Simion M, Rocchietta I, Kim D, Nevins M, Fiorellini J. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: A histologic study in a dog model. Int J Periodontics Restorative Dent 2006; 26:415-423.
45. Boyne P, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005; 63:1693-1707.
46. Fiorellini J, Howell TH, Cochran D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005; 76:605-613.
47. Wallace S, Froum S, Tarnow D. Histologic evaluation of a sinus elevation procedure: A clinical report. Int J Periodontics Restorative Dent 1996; 16:46-51.
48. Caterson E, Nesti LJ, Albert T, Danielson K, Tuan R. Application of mesenchymal stem cells in the regeneration of musculoskeletal tissues. MedGenMed 2001 Feb 5:E1.
49. McLain R, Fleming JE, Boehm CA, Muschler GF. Aspiration of osteoprogenitor cells for augmenting spinal fusion: Comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005; 87:2655-2661.
50. Muschler G, Nitto H, Boehm CA, Easley KA. Age-and genderrelated changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001; 19:117-125.
51. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000; 28:707-715.
52. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002; 405:14-23.
53. Cuomo A, Virk M, Petrigliano F, Morgan EF, Lieberman JR. Mesenchymal stem cell concentration and bone repair: Potential pitfalls from bench to bedside. J Bone Joint Surg Am 2009; 91:1073-1083.
54. Lane J, Yasko AW, Tomin E, et al. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop Relat Res 1999; 361:216-227.
55. Deans R, Moseley A. Mesenchymal stem cells biology and potential clinical uses. Exp Hematol 2000; 28:875-884.
56. Haynesworth S, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13:81-88.
57. Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci 2005; 12:47-57.
58. Tse W, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003; 75:389-397.